Additional file 6 of BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy

Additional file 6: Table S2. Fluorophore conjugated flow cytometry antibodies used to analyze the composition of the ovarian tumour microenvironment. All antibodies, with the exception of BV510, were diluted in PBS + 2% FBS. The viability BV510 stain was diluted in PBS only.